Moderna Posts Q2 Beat, Closes In On Coronavirus Vaccine Deal With Swiss Government

Moderna Inc shares were moving to the downside Wednesday despite the coronavirus vaccine developer reporting forecast-beating second-quarter results and reports of a potential deal with the Swiss government.